Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025)
Tiziana Life Sciences (TLSA) posted Assets Average of $14.0 million for Q4 2025, up 0.76% on a QoQ basis from $13.9 million in Q2 2025, and up 26.27% year-over-year from $11.1 million in Q4 2024.
Analysis
Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025) Analysis & Trends
Tiziana Life Sciences has reported Assets Average for 8 years, with the latest figure at $14.0 million in Q4 2025.
- On a quarterly basis, Assets Average rose 26.27% year-over-year to $14.0 million in Q4 2025; TTM through Dec 2025 was $14.0 million, a 26.27% increase from a year earlier, with the FY2025 full-year figure at $11.4 million, down 2.94% from the prior year.
- Assets Average was $14.0 million for Q4 2025 at Tiziana Life Sciences, up from $13.9 million in the prior quarter.
- The five-year high for Assets Average was $64.3 million in Q2 2021, with the low at $11.1 million in Q4 2024.
- Average Assets Average over 5 years is $27.8 million, with a median of $18.4 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2023: Assets Average soared 737.15% in 2021, then slumped 51.95% in 2023.
- Over 5 years, Assets Average stood at $53.3 million in 2021, then tumbled by 42.26% to $30.8 million in 2022, then tumbled by 51.95% to $14.8 million in 2023, then slipped by 24.84% to $11.1 million in 2024, then advanced by 26.27% to $14.0 million in 2025.
- The last three Assets Average figures came in at $14.0 million (Q4 2025), $13.9 million (Q2 2025), and $11.1 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Tiziana Life Sciences | 113.92 Mn | 113.92 Mn | - | 14.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 14.05 Mn |
| Jun 30, 2025 | 13.94 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Jun 30, 2024 | 11.57 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Jun 30, 2023 | 21.95 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Jun 30, 2022 | 41.98 Mn |
| Dec 31, 2021 | 53.35 Mn |
| Jun 30, 2021 | 64.26 Mn |
| Dec 31, 2020 | 41.84 Mn |
| Jun 30, 2020 | 7.68 Mn |
| Dec 31, 2019 | 2.51 Mn |
| Jun 30, 2019 | 4.85 Mn |
| Dec 31, 2018 | 4.39 Mn |
| Jun 30, 2018 | 2.11 Mn |